| Members |
targetComponentId |
| Potential infectious contact |
Exposure to organism (event) |
| Potential infectious contact |
Exposure to organism (event) |
| Potential infectious contact |
Exposure to organism (event) |
| Potexvirus group |
Genus Potexvirus (organism) |
| Pott's fracture |
Bimalleolar fracture of ankle |
| Pouched mammal |
Infraclass Metatheria (organism) |
| Pouchogram |
Fluoroscopy of ileal pouch with contrast (procedure) |
| Povidone 5% conventional release eye drops |
Povidone 50 mg/mL eye solution |
| Povidone 5% single-use eye drops |
Povidone 50 mg/mL eye solution |
| Povidone-iodine 10% |
Product containing povidone iodine (medicinal product) |
| Povidone-iodine 10% paint |
Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| Povidone-iodine 10% topical sponge |
Product containing precisely povidone iodine 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| Povidone-iodine 10% vaginal gel |
Iodine (as povidone iodine) 100 mg/g vaginal gel |
| Povidone-iodine 20% topical sponge |
Povidone iodine only product in cutaneous dose form |
| Povidone-iodine 200mg pessary |
Product containing precisely iodine (as povidone iodine) 200 milligram/1 each conventional release vaginal tablet (clinical drug) |
| Povidone-iodine 5% topical sponge |
Product containing precisely povidone iodine 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| Powder for conventional release intravesical or parenteral or urethral solution |
Powder for conventional release intravesical solution and solution for injection (dose form) |
| Powder for conventional release solution for endotracheal instillation |
Powder for solution for endotracheopulmonary instillation |
| Powder for conventional release suspension for endotracheal instillation |
Powder for conventional release suspension for endotracheopulmonary instillation (dose form) |
| Powder for suspension |
Powder (basic dose form) |
| Powered wheelchair |
Motorized wheelchair device (physical object) |
| Poxvirus group |
Family Poxviridae (organism) |
| Pramipexole dihydrochloride 125micrograms tablet |
Product containing precisely pramipexole (as pramipexole dihydrochloride) 88 microgram/1 each conventional release oral tablet (clinical drug) |
| Pramipexole dihydrochloride 1mg tablet |
Pramipexole (as pramipexole dihydrochloride) 700 microgram oral tablet |
| Pramipexole dihydrochloride 250micrograms tablet |
Pramipexole (as pramipexole dihydrochloride) 180 microgram oral tablet |
| Pramlintide 1mg/mL injection solution prefilled pen |
Pramlintide only product |
| Pre-eclampsia NOS |
Pre-eclampsia (disorder) |
| Pre-eclampsia NOS |
Pre-eclampsia (disorder) |
| Pre-eclampsia NOS |
Pre-eclampsia (disorder) |
| Pre-eclampsia or eclampsia with pre-existing hypertension with postnatal complication |
Pre-eclampsia or eclampsia with pre-existing hypertension |
| Pre-existing therapy altered by anesthetist preoperatively |
Pre-existing therapy altered by anesthetist preoperatively (situation) |
| Pre-primary teacher NOS |
Pre-primary education teacher |
| Pre-primary teacher NOS |
Pre-primary education teacher |
| Pre-school diphtheria and tetanus double vaccination |
Preschool administration of diphtheria and tetanus vaccine |
| Precautionary nursing procedure |
Nursing procedure |
| Precerebral artery occlusion NOS |
Precerebral arterial occlusion |
| Precerebral artery occlusion NOS |
Precerebral arterial occlusion |
| Precipitate labor with antenatal problem |
Precipitate labor |
| Prediabetes |
Prediabetes |
| Prednisolone 0.001% eye drops |
Prednisolone (as prednisolone sodium phosphate) 10 microgram/mL eye solution |
| Prednisolone 0.003% eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 30 microgram/1 milliliter conventional release eye solution (clinical drug) |
| Prednisolone 0.01% conventional release eye drops |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
| Prednisolone 0.01% eye drops |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
| Prednisolone 0.01% preservative-free eye drops |
Prednisolone (as prednisolone sodium phosphate) 100 microgram/mL eye solution |
| Prednisolone 0.03% conventional release eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
| Prednisolone 0.03% eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
| Prednisolone 0.03% preservative-free eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
| Prednisolone 0.1% conventional release eye drops |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
| Prednisolone 0.1% eye drops |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
| Prednisolone 0.1% preservative-free eye drops |
Prednisolone (as prednisolone sodium phosphate) 1 mg/mL eye solution |
| Prednisolone 0.3% conventional release eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
| Prednisolone 0.3% eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Prednisolone 0.3% preservative-free eye drops |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 300 microgram/1 milliliter conventional release eye solution (clinical drug) |
| Prednisolone 20mg/100mL enema |
Prednisolone only product in rectal dose form |
| Prednisolone 20mg/100mL enema |
Prednisolone only product in rectal dose form |
| Prednisolone 20mg/100mL long tube retention enema |
Prednisolone only product in rectal dose form |
| Prednisolone 20mg/100mL standard tube retention enema |
Prednisolone only product in rectal dose form |
| Prednisolone acetate + sulfacetamide sodium 5mg/100mg ointment |
Prednisolone and sulfacetamide only product in ocular dose form |
| Prednisolone acetate 25mg/mL |
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) |
| Prednisolone acetate 25mg/mL suspension |
Product containing precisely prednisolone 25 milligram/1 milliliter conventional release eye suspension (clinical drug) |
| Prednisolone drops allergy |
Allergy to prednisolone |
| Prednisolone hexanoate 1.3mg / Cinchocaine 1mg suppository |
Product containing precisely cinchocaine 1 milligram and prednisolone (as prednisolone sodium phosphate) 1.3 milligram/1 each conventional release rectal suppository (clinical drug) |
| Prednisolone sodium phosphate 0.5% conventional release eye drops |
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
| Prednisolone sodium phosphate 0.5% single-use eye drops |
Prednisolone (as prednisolone sodium phosphate) 5 mg/mL eye solution |
| Prednisolone sodium phosphate 1% solution |
Product containing precisely prednisolone sodium phosphate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
| Prednisolone sodium phosphate 1/8% solution |
Product containing precisely prednisolone 1.25 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Prefabricated stainless steel crown, permanent tooth |
Restoration of permanent tooth with preformed stainless steel crown (procedure) |
| Prefabricated stainless steel crown, primary tooth |
Restoration of deciduous tooth with preformed stainless steel crown (procedure) |
| Preference for temperature of drink |
Preference for temperature of drink (observable entity) |
| Preference for temperature of food |
Preference for temperature of food (observable entity) |
| Preglaucoma |
Glaucoma suspect |
| Pregnancy and drug dependence |
Pregnancy and substance dependence (disorder) |
| Pregnancy benefit NOS |
Pregnancy benefits |
| Pregnancy benefit NOS |
Pregnancy benefits |
| Pregnancy complications NOS |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
| Pregnancy complications NOS |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
| Pregnancy delivered |
Pregnancy observable |
| Pregnancy prolonged - 41 weeks |
Prolonged pregnancy (disorder) |
| Pregnancy prolonged - 42 weeks |
Prolonged pregnancy (disorder) |
| Pregnancy with abortive outcome NOS |
Pregnancy with abortive outcome |
| Pregnancy with abortive outcome NOS |
Pregnancy with abortive outcome |
| Pregnancy with medical condition NOS |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
| Pregnancy with medical condition NOS |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
| Pregnancy with other medical condition |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
| Pregnancy with other medical condition |
Complication of pregnancy, childbirth and/or puerperium (disorder) |
| Pregnancy, childbirth and puerperal disorders |
Maternal disorder during antenatal and/or intrapartum and/or postpartum period |
| Pregnant woman |
Pregnancy |
| Premature abnormal placenta |
Premature aging of placenta |
| Premature infancy |
Preterm infant less than 37 completed weeks gestation (finding) |
| Premature infant |
Preterm infant less than 37 completed weeks gestation (finding) |
| Premature rupture of membranes with antenatal problem |
Premature rupture of membranes |
| Prematurity of fetus |
Prematurity of infant (disorder) |
| Prenatal vitamin |
Vitamin |
| Preoperative nursing procedure |
Preoperative care |
| Preoperative procedures |
Preoperative procedure |
| Preputial skin flap |
Skin flap (substance) |
| Prescription telephone order |
Prescription ordered by telephone |
| Presence of complement |
Complement assay |
| Presence of complement component 3 |
Complement assay |
| Presence of complement component 4 |
Complement assay |
| Presence of drugs of abuse |
Drug, confirmation assay |
FHIR